Moderna Dividend yield

 Price  172.26
 Dividend  0.00
 Earnings  30.22
 Cash-flow  33.78
 Book value  35.16
 Equity  0.00

Moderna is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Moderna is a company from USA, and his stocks are publicly traded.

Moderna paid a total dividend of 0 million USD last year, for a market value of 69,249 millions (Market Cap 58,203 millions). Dividend per share of Moderna is 0.00 USD, and his stock market price 172.26 USD.

According to the chart below where dividend yield is displayed, Moderna, has a dividend yield of 0%, amount in contrast with the positive dividend offered by both the market average and companies from USA, Health Care industry, and Pharmaceuticals and Biotechnology sector. This lack of dividends of Moderna might harm the evolution of share price if the company is not clearly expanding his business.

In addition, you should compare Moderna dividend yield with other Pharmaceuticals and Biotechnology companies or firms from USA.

Dividend yield of Moderna

Moderna Dividend Payout

About the ability of Moderna to maintain his current dividend of USD 0.00 per share, an amount that accounts for 0.00%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Moderna payout on ernings is currently 0.00%, which is lower than the market average and companies in his industry and sector.

The following figure shows payout ratios over earnings and cashflow of Moderna, compared againt world market average, USA companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Moderna payout

Moderna Dividend History

Year Yield  USD  Paypout  Shares* 

*In millions

Moderna Stock performance

Finally, last moth Moderna showed a return of 12.10% compared to a worldwide 1.12% average, and a 1.32% of Health Care firms. Over the last year, the company obtained a 31.50% versus a worldwide performance of a 5.73%. More detailed information can be seen in the following graph for USA and Pharmaceuticals and Biotechnology firms.

Moderna stock and market return